SectorPharmaceutical
Established Date21/07/2015
Listing Date24/05/2018
ExchangeNASDAQ Stock Exchange
Full-time Employees315
Fiscal Year Ends31/12
Security TypeCommon stock
Office address23 Old Bond Street, Floor 3, London, WIS 4PZ, England, United Kingdom
Business
IntroductionKiniksa Pharmaceuticals International, plc was established in Bermuda on July 21, 2015. The company changed its registration from Bermuda to the United Kingdom on June 28, 2024. The Company is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic drugs for patients with debilitating diseases with serious unmet medical needs. The company's immunomodulatory combinations ARCALYST, KPL-404 and mavrilimumab target a range of undertreated cardiovascular and autoimmune diseases based on strong biological principles or proven mechanisms, and offer the potential for differentiation.
